PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-51.66%
Revenue decline while CRK shows 10.33% growth. Joel Greenblatt would examine competitive position erosion.
-5.04%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-93.69%
Gross profit decline while CRK shows 33.21% growth. Joel Greenblatt would examine competitive position.
-86.94%
Margin decline while CRK shows 39.47% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-12.36%
G&A reduction while CRK shows 1.58% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-127.59%
Other expenses reduction while CRK shows 11.74% growth. Joel Greenblatt would examine efficiency.
-14.04%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-10.41%
Both companies reducing total costs. Martin Whitman would check industry trends.
3.88%
Interest expense growth while CRK reduces costs. John Neff would investigate differences.
-11.88%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-131.33%
EBITDA decline while CRK shows 319.20% growth. Joel Greenblatt would examine position.
-2.96%
EBITDA margin decline while CRK shows 188.72% growth. Joel Greenblatt would examine position.
-226.72%
Operating income decline while CRK shows 59.81% growth. Joel Greenblatt would examine position.
-575.87%
Operating margin decline while CRK shows 63.57% growth. Joel Greenblatt would examine position.
-142.98%
Other expenses reduction while CRK shows 532.20% growth. Joel Greenblatt would examine advantage.
-57.06%
Pre-tax income decline while CRK shows 109.48% growth. Joel Greenblatt would examine position.
-224.90%
Pre-tax margin decline while CRK shows 108.59% growth. Joel Greenblatt would examine position.
-55.15%
Both companies reducing tax expense. Martin Whitman would check patterns.
-58.58%
Net income decline while CRK shows 108.58% growth. Joel Greenblatt would examine position.
-228.04%
Net margin decline while CRK shows 107.77% growth. Joel Greenblatt would examine position.
-57.78%
EPS decline while CRK shows 107.18% growth. Joel Greenblatt would examine position.
-58.74%
Diluted EPS decline while CRK shows 107.18% growth. Joel Greenblatt would examine position.
0.51%
Share count reduction exceeding 1.5x CRK's 16.71%. David Dodd would verify capital allocation.
No Data
No Data available this quarter, please select a different quarter.